Jacobitz Alex W, Kattke Michele D, Wereszczynski Jeff, Clubb Robert T
The Molecular Biology Institute and the UCLA-DOE Institute of Genomics and Proteomics, University of California, Los Angeles, CA, United States.
Center for Molecular Study of Condensed Soft Matter, Illinois Institute of Technology, Chicago, IL, United States.
Adv Protein Chem Struct Biol. 2017;109:223-264. doi: 10.1016/bs.apcsb.2017.04.008. Epub 2017 Jun 5.
Gram-positive bacteria use sortase cysteine transpeptidase enzymes to covalently attach proteins to their cell wall and to assemble pili. In pathogenic bacteria sortases are potential drug targets, as many of the proteins that they display on the microbial surface play key roles in the infection process. Moreover, the Staphylococcus aureus Sortase A (SaSrtA) enzyme has been developed into a valuable biochemical reagent because of its ability to ligate biomolecules together in vitro via a covalent peptide bond. Here we review what is known about the structures and catalytic mechanism of sortase enzymes. Based on their primary sequences, most sortase homologs can be classified into six distinct subfamilies, called class A-F enzymes. Atomic structures reveal unique, class-specific variations that support alternate substrate specificities, while structures of sortase enzymes bound to sorting signal mimics shed light onto the molecular basis of substrate recognition. The results of computational studies are reviewed that provide insight into how key reaction intermediates are stabilized during catalysis, as well as the mechanism and dynamics of substrate recognition. Lastly, the reported in vitro activities of sortases are compared, revealing that the transpeptidation activity of SaSrtA is at least 20-fold faster than other sortases that have thus far been characterized. Together, the results of the structural, computational, and biochemical studies discussed in this review begin to reveal how sortases decorate the microbial surface with proteins and pili, and may facilitate ongoing efforts to discover therapeutically useful small molecule inhibitors.
革兰氏阳性菌利用分选酶半胱氨酸转肽酶将蛋白质共价连接到其细胞壁上并组装菌毛。在致病细菌中,分选酶是潜在的药物靶点,因为它们在微生物表面展示的许多蛋白质在感染过程中起关键作用。此外,金黄色葡萄球菌分选酶A(SaSrtA)已被开发成为一种有价值的生化试剂,因为它能够在体外通过共价肽键将生物分子连接在一起。在这里,我们综述了关于分选酶的结构和催化机制的已知信息。基于它们的一级序列,大多数分选酶同源物可分为六个不同的亚家族,称为A-F类酶。原子结构揭示了独特的、类特异性的变异,这些变异支持不同的底物特异性,而与分选信号模拟物结合的分选酶结构则揭示了底物识别的分子基础。综述了计算研究的结果,这些结果深入了解了关键反应中间体在催化过程中是如何稳定的,以及底物识别的机制和动力学。最后,比较了已报道的分选酶的体外活性,结果表明SaSrtA的转肽活性比迄今为止已被表征的其他分选酶至少快20倍。总之,本综述中讨论的结构、计算和生化研究结果开始揭示分选酶如何用蛋白质和菌毛装饰微生物表面,并可能促进正在进行的发现具有治疗用途的小分子抑制剂的努力。